EGFR and non-small cell lung carcinoma: This regulatory relationship is further reinforced by STAT3-mediated transcription of PLK1, establishing a robust positive feedback loop that not only reduces sensitivity to EGFR-TKIs in EGFR-mutant NSCLC but also significantly impacts patient prognosis.